fda tirzepatide shortage resolved 2025 Ends Compounded GLP-1s: What to Know fda shortage semaglutide injection resolved

Current evidence does not establish a definitive causal link between GLP-1 receptor agonists and pancreatitis, though UK regulatory guidance lists it as a possible risk

Track your weight at the same time each day, ideally first thing in the morning after using the bathroom, to give your provider the most consistent data possible for making dose adjustment decisions

28% of East Asia's category sales came from China by 2030

Constipation and diarrhea each affected roughly 10-16% of participants

Tirzepatide injections are administered once a week

These drugs mimic the activity of glucagon-like peptide-1 (GLP-1), a hormone naturally released by the intestines after eating